Cavone L - Search Results

1

Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.

Cavone L, Felici R, Lapucci A, Buonvicino D, Pratesi S, Muzzi M, Hakiki B, Maggi L, Peruzzi B, Caporale R, Annunziato F, Amato MP, Chiarugi A. Cavone L, et al. Brain Behav Immun. 2015 Nov;50:78-86. doi: 10.1016/j.bbi.2015.06.019. Epub 2015 Jun 27. Brain Behav Immun. 2015. PMID: 26130058

2

Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?

Cavone L, Chiarugi A. Cavone L, et al. Trends Mol Med. 2012 Feb;18(2):92-100. doi: 10.1016/j.molmed.2011.10.002. Epub 2011 Nov 9. Trends Mol Med. 2012. PMID: 22078487 Review.

3

Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses.

Felici R, Buonvicino D, Muzzi M, Cavone L, Guasti D, Lapucci A, Pratesi S, De Cesaris F, Luceri F, Chiarugi A. Felici R, et al. Among authors: cavone l. Neuropharmacology. 2017 May 1;117:74-84. doi: 10.1016/j.neuropharm.2017.01.039. Epub 2017 Feb 1. Neuropharmacology. 2017. PMID: 28161373

4

Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.

Cavone L, Peruzzi B, Caporale R, Chiarugi A. Cavone L, et al. Br J Pharmacol. 2014 Mar;171(6):1501-9. doi: 10.1111/bph.12525. Br J Pharmacol. 2014. PMID: 24730062 Free PMC article.

5

PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.

Cavone L, Aldinucci A, Ballerini C, Biagioli T, Moroni F, Chiarugi A. Cavone L, et al. Mult Scler. 2011 Jul;17(7):794-807. doi: 10.1177/1352458511399113. Epub 2011 Feb 22. Mult Scler. 2011. PMID: 21343230

6

Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes.

Pittelli M, Cavone L, Lapucci A, Oteri C, Felici R, Niccolai E, Amedei A, Chiarugi A. Pittelli M, et al. Among authors: cavone l. Immunol Cell Biol. 2014 Feb;92(2):191-9. doi: 10.1038/icb.2013.85. Epub 2013 Nov 26. Immunol Cell Biol. 2014. PMID: 24275857

7

PARP inhibition delays progression of mitochondrial encephalopathy in mice.

Felici R, Cavone L, Lapucci A, Guasti D, Bani D, Chiarugi A. Felici R, et al. Among authors: cavone l. Neurotherapeutics. 2014 Jul;11(3):651-64. doi: 10.1007/s13311-014-0285-y. Neurotherapeutics. 2014. PMID: 24935635 Free PMC article.

8

Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I-Mutant Fibroblasts.

Felici R, Lapucci A, Cavone L, Pratesi S, Berlinguer-Palmini R, Chiarugi A. Felici R, et al. Among authors: cavone l. Mol Pharmacol. 2015 Jun;87(6):965-71. doi: 10.1124/mol.114.097204. Epub 2015 Mar 18. Mol Pharmacol. 2015. PMID: 25788480

9

Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice.

Lapucci A, Cavone L, Buonvicino D, Felici R, Gerace E, Zwergel C, Valente S, Mai A, Chiarugi A. Lapucci A, et al. Among authors: cavone l. Neurosci Lett. 2017 Aug 24;656:120-125. doi: 10.1016/j.neulet.2017.07.033. Epub 2017 Jul 19. Neurosci Lett. 2017. PMID: 28732762

10

Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice.

Buonvicino D, Felici R, Ranieri G, Caramelli R, Lapucci A, Cavone L, Muzzi M, Di Pietro L, Bernardini C, Zwergel C, Valente S, Mai A, Chiarugi A. Buonvicino D, et al. Among authors: cavone l. Neuroscience. 2018 May 21;379:228-238. doi: 10.1016/j.neuroscience.2018.03.022. Epub 2018 Mar 26. Neuroscience. 2018. PMID: 29588251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters